NC-6300
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NC-6300, covering 2020-02-28 to 2020-02-28. Get the full timeline:
Most recent: Clinical Trial Update: Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma [Phase 1, Phase 2]